|
Net Sales
|
: 7.50 %*† / FY09
|
|
GAAP EPS
|
: 12.00 %* / FY09
|
|
Release Date
|
: 09/16/2009
|
|
Release Date
|
: 09/16/2009
|
|
Release Date
|
: 09/16/2009
|
|
Net Sales
|
: (15.00) %* / FY09
|
|
Release Date
|
: 09/16/2009
|
|
|
|
|
|
Baxter International Inc.(BAX)
|
|
|
|
|
|
|
| |
Currency |
USD |
Latest Earnings Date
|
08/12/2009
|
|
|
| |
Country |
United States |
Latest Guidance Date |
09/16/2009 |
|
|
| |
Industry |
Pharmaceuticals & Biotech |
Values |
Midpoint |
|
|
|
|
| |
Guidance Revision Trend |
| |
|
| |
|
| |
| Sales |
|
 |
 |
 |
 |
| Adjusted EPS |
|
 |
 |
 |
|
| Reported EPS |
 |
 |
 |
 |
 |
|
|